Editorial: Tumor Necrosis Factor Antagonists: Killing Two Birds With One Biologic Stone

Arthritis Rheumatol. 2018 Mar;70(3):326-329. doi: 10.1002/art.40376. Epub 2018 Feb 13.

Authors

Joan M Bathon¹, Jon T Giles¹, Daniel H Solomon²

Affiliations

¹ Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York.
² Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Atherosclerosis*
Biological Products
Humans
Tumor Necrosis Factor-alpha*

Substances

Biological Products
Tumor Necrosis Factor-alpha

Grants and funding